NewsMarkets

Health

DEA Bans Potential Opioid Withdrawal Drug SR-17018

The DEA classifies the substance as a Schedule I drug, overriding reports from users on Reddit and Discord that it alleviates withdrawal symptoms.

2 publishers · 2 articles · first seen 3 Nov 2026 · updated 1h ago

Headline and summary written by an AI model from the linked articles; not reviewed by a person. How this was made

The story so far

2 publishers have covered this in 2 articles since 3 Nov 2026. Feed: All Latest published first, on 3 November at 10:00 UTC; Ars Technica followed 29h 09m later. The most recent article, from Ars Technica, appeared on 4 November at 15:08 UTC.

Outlets reporting it: Feed: All Latest (major outlet), Ars Technica (major outlet).

No prediction market is linked to this story at the moment. We match each story to Polymarket and Kalshi markets by what they ask, and show one only when it is close enough to be useful; if a market on this topic opens, it will appear here. Meanwhile, browse every market we track or see how stories and markets are matched.

Sources

Every article we clustered into this story. Headlines link to the publisher.

  1. The DEA banned a drug some opioid users called a miracle Ars Technica ·
  2. Opioid Users Found a ‘Miracle Drug’ to Help Them Quit. Then the DEA Banned It Feed: All Latest ·

In this story

Embed this story

Paste this into any web page to show the live odds, with a link back here.